Helping Cambodian people living with HIV quit smoking using tailored smartphone messages and support
Ending Tobacco Use through Interactive Tailored Messaging for Cambodian People Living with HIV/AIDS (EndIT)
['FUNDING_U01'] · H. LEE MOFFITT CANCER CTR & RES INST · NIH-11163553
A program offers personalized smartphone messages plus medication and counseling to help Cambodian adults living with HIV stop smoking.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | H. LEE MOFFITT CANCER CTR & RES INST (nih funded) |
| Locations | 1 site (TAMPA, UNITED STATES) |
| Trial ID | NIH-11163553 on ClinicalTrials.gov |
What this research studies
This project offers people living with HIV in Cambodia a combined quitting program that includes medicine, counseling, and an automated interactive smartphone messaging system. Participants will be enrolled through local HIV clinics and randomly assigned to the intervention or usual care so researchers can compare outcomes. The messaging app is tailored to each person's smoking patterns and readiness to quit and provides real-time tips and motivation without needing frequent clinic visits. The team has already built the mobile platform and completed a small pilot with 50 participants, and this larger trial will follow people over time to track smoking and health outcomes.
Who could benefit from this research
Good fit: Cambodian adults living with HIV who currently smoke cigarettes, are receiving HIV care (ART), and have access to a smartphone are ideal candidates.
Not a fit: People who do not smoke, are not living with HIV, lack access to a smartphone, or do not want to use mobile-based support are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the program could help people with HIV in Cambodia stop smoking, improve their overall health, and extend life expectancy.
How similar studies have performed: Combined medication-plus-behavior interventions and mHealth programs have helped smokers in other countries, and the team completed a small pilot with Cambodian PLWH showing feasibility.
Where this research is happening
TAMPA, UNITED STATES
- H. LEE MOFFITT CANCER CTR & RES INST — TAMPA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VIDRINE, DAMON J. — H. LEE MOFFITT CANCER CTR & RES INST
- Study coordinator: VIDRINE, DAMON J.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus